# CalciMedica, Inc. Common Stock (CALC)

> CalciMedica, Inc. Common Stock (CALC) trades at $1.26 (+7.69%) as of 7:30:05 PM EST on Nov 20, 2026, +9.57% over the past month. Market cap is $8.69M, with 1.8 days to cover in short interest.

Canonical: https://massive.com/quote/calc
Data as of: 2026-11-21T00:30:05.585Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$1.26** +0.09 (+7.69%)
At close · 15-minute delayed
Nasdaq · usd

After hours: **$1.30** +0.04 (+3.17%)
As of 7:30:05 PM EST on Nov 20, 2026 · After hours

## Stock performance

How CalciMedica, Inc. Common Stock (CALC) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | +7.69% |
| 1W | +4.13% |
| 1M | +9.57% |
| YTD | -96.18% |
| 1Y | -93.99% |
| 52-wk range | $1.00 – $36.00 |

From daily closes through Nov 20, 2026.

## Key statistics

Today's trading snapshot for CALC: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $1.20 – $1.33 |
| Open | $1.28 |
| Prev close | $1.17 |
| Volume | 91.27K |
| Market cap | $8.69M |
| Shares out | 6.9M |

## Valuation and profitability ratios

Valuation and profitability ratios for CalciMedica, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

| Measure | Value |
| --- | --- |
| P/E | — |
| P/S | — |
| P/B | 2.06 |
| P/FCF | — |
| ROE | -357.5% |
| ROA | -105.7% |
| Debt/Equity | 1.63 |
| Div yield | 0.00% |

As of Nov 20, 2026

## Insider trading

[CalciMedica, Inc. Common Stock (CALC) insider trading](https://massive.com/quote/calc/insider-trading.md): open-market Form 4 buys and sells by CalciMedica, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events CalciMedica, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 10, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On November 10, 2026, CalciMedica, Inc. issued a press release announcing its financial results for the fiscal quarter ended September 30, 2026.”
- Oct 16, 2026 · [Cfo departure](https://massive.com/quote/sec-filings/8-k/executive-departures.md)
  “On October 15, 2026, Stephen Bardin, the Chief Financial Officer, principal accounting officer and principal financial officer of CalciMedica, Inc. (the "Company"), provided notice of his resignation, to be effective immediately following the filing of the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, to pursue another professional opportunity. Mr. Bardin's resignation was not due to any disagreement with the Company.”
- Sep 30, 2026 · Underwriting agreement
  “The Company may offer and sell Common Stock having an aggregate offering price of up to $25,000,000 from time to time under the Company's at-the-market offering agreement (the "Offering Agreement") with H.C. Wainwright & Co., dated August 11, 2023.”
- Sep 16, 2026 · [Listing compliance regained](https://massive.com/quote/sec-filings/8-k/delisting-notices.md)
  “On September 15, 2026, the Company received a letter from the Staff notifying the Company that the Staff has determined that for 10 consecutive business days, from August 31, 2026 to September 14, 2026, the closing bid price of the Company's common stock has been at $1.00 per share or greater. Accordingly, the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2).”
- Sep 2, 2026 · [Stock split](https://massive.com/quote/sec-filings/8-k/stock-splits.md)
  “As previously disclosed, at 5:00 p.m. (Eastern Time) on August 28, 2026, the Company implemented a one-for-five reverse stock split of its outstanding common stock.”

## Dividend history and stock splits

CalciMedica, Inc. Common Stock's recent dividend payments and stock splits.

### Dividends

No recent dividends.

### Splits

- 1-for-5 · Aug 31, 2026
- 1-for-14 · Mar 20, 2023

## CALC short interest

How heavily CALC is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 1.8 |
| Short interest | 171.39K |
| Avg volume | 96.5K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## CALC news

The latest news and headlines about CalciMedica, Inc. Common Stock (CALC).

- [What Makes CalciMedica Inc. (CALC) a New Buy Stock](https://www.zacks.com/stock/news/3028906/what-makes-calcimedica-inc-calc-a-new-buy-stock?cid=CS-ZC-FT-fundamental_analysis|yseop_template_12_zacks_rank_upgrade-3028906) · Zacks Investment Research · Nov 12, 2026 · positive sentiment
- [Hypertension Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry \| DelveInsight](https://www.globenewswire.com/news-release/2026/09/16/3363442/0/en/hypertension-clinical-trial-pipeline-accelerates-as-100-pharma-companies-rigorously-develop-drugs-for-market-entry-delveinsight.html) · GlobeNewswire Inc. · Sep 16, 2026 · positive sentiment
- [Is Alcon (ALC) Stock Outpacing Its Medical Peers This Year?](https://www.zacks.com/stock/news/2277853/is-alcon-alc-stock-outpacing-its-medical-peers-this-year) · Zacks Investment Research · May 23, 2024
- [CalciMedica And 2 Other Penny Stocks Insiders Are Buying](https://www.benzinga.com/trading-ideas/long-ideas/24/04/38067894/calcimedica-and-2-other-penny-stocks-insiders-are-buying) · Benzinga · Apr 3, 2024
- [Top 4 Health Care Stocks That May Crash This Quarter](https://www.benzinga.com/news/24/02/36908496/top-4-health-care-stocks-that-may-crash-this-quarter) · Benzinga · Feb 2, 2024

## About CalciMedica, Inc. Common Stock

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys. The company operates as one operating segment focused on developing and commercializing therapeutics in the U.S.

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 12 |
| Listed | Sep 25, 2020 |

[Company website](https://www.calcimedica.com)

## FAQ

### What is the CalciMedica, Inc. Common Stock (CALC) stock price today?

CalciMedica, Inc. Common Stock (CALC) is trading at $1.26 (+7.69% on the day) as of 7:30:05 PM EST on Nov 20, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is CalciMedica, Inc. Common Stock?

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage.

### What is the short interest in CALC?

As of Oct 30, 2026, CALC has 171.39K shares short and 1.8 days to cover.

### What exchange is CALC listed on?

CalciMedica, Inc. Common Stock (CALC) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time CALC quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=CALC`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [CalciMedica, Inc. Common Stock (CALC) insider trading](https://massive.com/quote/calc/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
